Global Health Study Validates Biospectal OptiBP Mobile Blood Pressure Measurement App Accuracy Across Diverse Settings
Biospectal SA , the remote patient monitoring and biosensing software company, today announced the publication of global health study results published in Nature’s NPJ Digital Medicine of the first independent research and validation study to use Biospectal’s mobile blood pressure monitoring app, OptiBP™ in low-resource urban and rural settings.
- Biospectal SA , the remote patient monitoring and biosensing software company, today announced the publication of global health study results published in Nature’s NPJ Digital Medicine of the first independent research and validation study to use Biospectal’s mobile blood pressure monitoring app, OptiBP™ in low-resource urban and rural settings.
- The Biospectal OptiBP app calculates pressure using pulse wave analysis through a smartphone’s camera lens.
- Biospectal’s OptiBP app was identified in the WHO Compendium of Innovative Health Technologies along with Grand Challenges Canada as an innovative solution for low-resource health systems.
- “This research shows that OptiBP has the potential to transform lives and improve global health by offering people a simple yet painstakingly reliable way to track their blood pressure.